Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Immunogenicity Using a Combination of DNA and Vaccinia Virus Vector Vaccines

  • Read more about Immunogenicity Using a Combination of DNA and Vaccinia Virus Vector Vaccines
US Patent 7,094,408
Filed on 2002-10-25

Utilization of Non-Viral Sequences for Minus-Strand DNA Transfer and Gene Reconstitution

  • Read more about Utilization of Non-Viral Sequences for Minus-Strand DNA Transfer and Gene Reconstitution
US Patent 7,101,541
Filed on 2003-05-21

Method of Inhibiting Viral Replication Targeting the Nucleocapsid Protein

  • Read more about Method of Inhibiting Viral Replication Targeting the Nucleocapsid Protein
European Patent
02726567.7
Filed on 2002-02-05

Peptide Agonists of Prostate-Specific Antigen (PSA), and Uses Therefor

  • Read more about Peptide Agonists of Prostate-Specific Antigen (PSA), and Uses Therefor
Patent Cooperation Treaty
PCT/US2002/037805
Filed on 2002-11-26

BASAL CELL CARCINOMA TUMOR SUPPRESSOR PROTEIN

  • Read more about BASAL CELL CARCINOMA TUMOR SUPPRESSOR PROTEIN
US Patent 7,317,086
Filed on 2002-11-22

Use of Mx GTPases in The Prognosis And Treatment of Cancer

  • Read more about Use of Mx GTPases in The Prognosis And Treatment of Cancer
Patent Cooperation Treaty
PCT/US02/33232
Filed on 2002-10-18

PEPTIDE T STIMULATES CTL RESPONSES

  • Read more about PEPTIDE T STIMULATES CTL RESPONSES
Patent Cooperation Treaty
PCT/US02/39109
Filed on 2002-12-06

Generation And Use of Tc1 And Tc2 Cells

  • Read more about Generation And Use of Tc1 And Tc2 Cells
Patent Cooperation Treaty
PCT/US02/35240
Filed on 2002-10-31

Molecular Clones With Mutated HIV GAG/POL,SIV GAG And SIV ENV Genes

  • Read more about Molecular Clones With Mutated HIV GAG/POL,SIV GAG And SIV ENV Genes
US Patent 8,076,100
Filed on 2002-10-02

Peptide Inhibitors of Yersinia Phosphatase (YopH) As Potential Treatments Against Plague

  • Read more about Peptide Inhibitors of Yersinia Phosphatase (YopH) As Potential Treatments Against Plague
US Application 10/341,607
Filed on 2003-01-14

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1138
  • Page 1139
  • Page 1140
  • Page 1141
  • Page 1142
  • Page 1143
  • Page 1144
  • Page 1145
  • Page 1146
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health